文献速递传染病防控与疫情报告卫生政策与健康促进

美国指定机场入境旅客COVID-19风险评估与管理(2020年1月17日至9月13日)

Risk Assessment and Management of COVID-19 Among Travelers Arriving at Designated U.S. Airports, January 17-September 13, 2020.
PubMed 文献 · MMWR Morb Mortal Wkly Rep · 2020-11-13

2020年1月至9月,CDC在国土安全部支持下对来自SARS-CoV-2广泛持续传播国家的航空旅客实施强化入境风险评估与管理(筛查)项目,共筛查766,044名旅客,其中298人(0.04%)符合公共卫生评估标准,35人(0.005%)接受SARS-CoV-2检测,9人(0.001%)检测阳性。该资源密集型项目的低病例发现率凸显美国边境卫生策略需根本性改变,症状筛查对COVID-19病例发现无效。

要点

  • 共筛查766,044名旅客,仅0.04%符合公共卫生评估标准,0.001%检测阳性。
  • 因数据收集困难及部分州选择退出,CDC仅与州共享约68%筛查旅客的联系信息。
  • 症状筛查对COVID-19病例发现无效,需转向出发前/到达后检测和健康申报等策略。

核心结论

  • 该资源密集型筛查项目的低病例发现率(0.001%阳性)表明美国边境卫生策略需根本性改变。
  • 基于症状的筛查对COVID-19病例发现无效,因感染和传播可无症状且症状非特异。

研究设计与样本

  • 2020年1月17日至9月13日,CDC与DHS合作在指定美国机场对来自SARS-CoV-2广泛持续传播国家的航空旅客实施强化入境风险评估与管理(筛查)项目。

主要发现

  • 共筛查766,044名旅客,其中298人(0.04%)符合公共卫生评估标准。
  • 35人(0.005%)接受SARS-CoV-2检测,9人(0.001%)检测阳性。
  • CDC与州共享约68%筛查旅客的联系信息,因数据收集挑战和部分州选择退出。

临床怎么用

  • 筛查项目于2020年9月14日结束,后续措施聚焦加强旅客沟通以促进预防措施、强化转介明显患病旅客至CDC及增强入境口岸公共卫生应对能力。
  • 建议在旅客到达前更高效收集国际航空旅客联系信息并实时传输至美国卫生部门,以促进及时到达后公共卫生管理(包括接触者追踪)。
  • 纳入健康申报、出发前和到达后检测及较高风险旅行后限制活动期,可能降低旅行中传播和SARS-CoV-2跨地区转移风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

In January 2020, with support from the U.S. Department of Homeland Security (DHS), CDC instituted an enhanced entry risk assessment and management (screening) program for air passengers arriving from certain countries with widespread, sustained transmission of SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19). The objectives of the screening program were to reduce the importation of COVID-19 cases into the United States and slow subsequent spread within states. Screening aimed to identify travelers with COVID-19-like illness or who had a known exposure to a person with COVID-19 and separate them from others. Screening also aimed to inform all screened travelers about self-monitoring and other recommendations to prevent disease spread and obtain their contact information to share with public health authorities in destination states. CDC delegated postarrival management of crew members to airline occupational health programs by issuing joint guidance with the Federal Aviation Administration.* During January 17-September 13, 2020, a total of 766,044 travelers were screened, 298 (0.04%) of whom met criteria for public health assessment; 35 (0.005%) were tested for SARS-CoV-2, and nine (0.001%) had a positive test result. CDC shared contact information with states for approximately 68% of screened travelers because of data collection challenges and some states' opting out of receiving data. The low case detection rate of this resource-intensive program highlighted the need for fundamental change in the U.S. border health strategy. Because SARS-CoV-2 infection and transmission can occur in the absence of symptoms and because the symptoms of COVID-19 are nonspecific, symptom-based screening programs are ineffective for case detection. Since the screening program ended on September 14, 2020, efforts to reduce COVID-19 importation have focused on enhancing communications with travelers to promote recommended preventive measures, reinforcing mechanisms to refer overtly ill travelers to CDC, and enhancing public health response capacity at ports of entry. More efficient collection of contact information for international air passengers before arrival and real-time transfer of data to U.S. health departments would facilitate timely postarrival public health management, including contact tracing, when indicated. Incorporating health attestations, predeparture and postarrival testing, and a period of limited movement after higher-risk travel, might reduce risk for transmission during travel and translocation of SARS-CoV-2 between geographic areas and help guide more individualized postarrival recommendations.

来源:MMWR Morb Mortal Wkly Rep,查看原文。版权归原作者所有。

引用

  1. Dollard P, Griffin I, Berro A, et al. Risk Assessment and Management of COVID-19 Among Travelers Arriving at Designated U.S. Airports, January 17-September 13, 2020. MMWR Morb Mortal Wkly Rep. 2020. PMID: 33180758. doi:10.15585/mmwr.mm6945a4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。